CE-Channel is pioneering innovative collaboration initiatives with Chinese enterprises, marking a new era in international market expansion. Through strategic partnerships and shared objectives, CE-Channel is poised to reshape the global business landscape and foster mutual success.
In today's dynamic business environment, collaboration is key to achieving sustainable growth and competitive advantage. CE-Channel recognizes the importance of forging strong alliances and leveraging collective strengths to capitalize on emerging opportunities in the international market.
With a focus on innovation and forward-thinking strategies, CE-Channel seeks to redefine the way Chinese enterprises approach international expansion. By harnessing cutting-edge technologies and industry expertise, we empower businesses to navigate the complexities of global markets with confidence and agility.
At the core of CE-Channel's approach is a commitment to fostering an environment of trust, transparency, and shared prosperity. We believe that by working together towards common goals, we can create value and drive positive impact on a global scale.
Join us as we embark on this transformative journey together. With CE-Channel as your strategic partner, the possibilities for collaboration and success are limitless. Let us join forces to unlock new opportunities and establish a lasting legacy in the international marketplace.
品牌創始人 Founder
林懿慧 Ivy Lin
Taiwan +886 958213993 (We chat )
China : +86 188 2023 4680
E mail : ivy@ce-channel.com
Web : www.ce-channel.com
Office :
深圳市龙岗区龙翔大道4075号星知航大厦7B
7B, Xingzhihang Building, No. 4075 Longxiang Avenue, Longgang District, Shenzhen
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17